Friendswood, Texas — According to state and local economic development sources Castle Biosciences plans to invest $1,500,000.00 to build out 21,760 square feet of new space in Friendswood. The company plans to occupy the new space at 505 S Friendswood Dr in Friendswood, on or about November 1, 2020. According to the company website Castle Biosciences develops and commercializes diagnostic and prognostic tests for dermatologic cancers. Our tests provide clinically actionable, tumor-specific genomic information to enable more accurate treatment plan decisions. We believe that the traditional approach to developing a treatment plan for dermatologic cancers using clinical and pathology factors alone is inadequate, and can be improved by incorporating personalized genomic information.

To learn more about Castle Biosciences, visit http://castlebiosciences.com/

Company Contact:
Derek Maetzold, Chief Executive Officer
https://www.linkedin.com/in/derek-maetzold-5070855/
866-788-9007

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved